2012Hebei yiyaoRequires access

Effects of different doses of atorvastatin on interleukin-6 and hypersensitive C-reactive protein in patients with unstable angina pectoris

LV Ha

Open publisher page 0 citations

Abstract

Objective To investigate the effects of different doses of atorvastatin on interleukin-6(IL-6)and hypersensitive C-reactive protein(hs-CRP)in patients with unstable angina pectoris(UAP).Methods 94 patients with UAP were randomly divided into three groups:the patients in control group were given routine therapy,the patients in control treatment group,on the basis of control group,were given atorvastatin 10mg,and the patients in treatment group were given atorvastatin 20mg,besides the conventional therapy.The levels of blood lipids,IL-6,hs-CRP were detected before and after the treatments.Results After treatment,the levels of blood lipids,IL-6 and hs-CRP in control treatment group and treatment group were significantly reduced,as compared with those before treatment (P0.01),furthermore the decrease in treatment group was more obvious than that in control treatment group (P0.01),however,the decrease of blood lipid levels before treatment in control treatment group and treatment group was not related with the decrease of levels of IL-6 and hs-CRP (P0.05).Conclusion The atorvastatin can reduce the levels of blood lipid,IL-6 and hs-CRP in patients with UAP,and the effect of atorvastatin 20mg is superior to that of atorvastatin 10mg,however,its anti-inflammatory effect is not independent of the effect of reducing blood lipid.

About this research paper

What this paper is about

Objective To investigate the effects of different doses of atorvastatin on interleukin-6(IL-6)and hypersensitive C-reactive protein(hs-CRP)in patients with unstable angina pectoris(UAP).Methods 94 patients with UAP were randomly divided into three groups:the patients in control group were given routine therapy,the patients in control treatment group,on the basis of control group,were given atorvastatin 10mg,and the patients in treatment group were given atorvastatin 20mg,besides the conventional therapy.The levels of blood lipids,IL-6,hs-CRP were detected before and after the treatments.Results After treatment,the levels of blood lipids,IL-6 and hs-CRP in control treatment group and treatment group were significantly reduced,as compared with those before treatment (P0.01),furthermore the decrease in treatment group was more obvious than that in control treatment group (P0.01),however,the decrease of blood lipid levels before treatment in control treatment group and treatment group was not related with the decrease of levels of IL-6 and hs-CRP (P0.05).Conclusion The atorvastatin can reduce the levels of blood lipid,IL-6 and hs-CRP in patients with UAP,and the effect of atorvastatin 20mg is superior to that of atorvastatin 10mg,however,its anti-inflammatory effect is not independent of the effect of reducing blood lipid.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of different doses of atorvastatin on interleukin-6(IL-6)and hypersensitive C-reactive protein(hs-CRP)in patients with unstable angina pectoris(UAP).Methods 94 patients with UAP were randomly divided into three groups:the patients in control group were given routine therapy,the patients in control treatment group,on the basis of control group,were given atorvastatin 10mg,and the patients in treatment group were given atorvastatin 20mg,besides the conventional therapy.The levels of blood lipids,IL-6,hs-CRP were detected before and after the treatments.Results After treatment,the levels of blood lipids,IL-6 and hs-CRP in control treatment group and treatment group were significantly reduced,as compared with those before treatment (P0.01),furthermore the decrease in treatment group was more obvious than that in control treatment group (P0.01),however,the decrease of blood lipid levels before treatment in control treatment group and treatment group was not related with the decrease of levels of IL-6 and hs-CRP (P0.05).Conclusion The atorvastatin can reduce the levels of blood lipid,IL-6 and hs-CRP in patients with UAP,and the effect of atorvastatin 20mg is superior to that of atorvastatin 10mg,however,its anti-inflammatory effect is not independent of the effect of reducing blood lipid.

Key concepts: Atorvastatin, Medicine, C-reactive protein, Blood lipids, Unstable angina, Internal medicine, Gastroenterology, Interleukin 6

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of different doses of atorvastatin on interleukin-6 and hypersensitive C-reactive protein in patients with unstable angina pectoris — Research Paper | ScholarLens